LOS ANGELES CAPITAL MANAGEMENT LLC - PDL BIOPHARMA INC ownership

PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 223 filers reported holding PDL BIOPHARMA INC in Q4 2013. The put-call ratio across all filers is 0.28 and the average weighting 0.1%.

Quarter-by-quarter ownership
LOS ANGELES CAPITAL MANAGEMENT LLC ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q1 2014$348,000
-12.1%
41,917
-10.6%
0.00%0.0%
Q4 2013$396,000
+4.2%
46,862
-1.6%
0.00%
-20.0%
Q3 2013$380,000
+5.6%
47,622
+2.0%
0.01%0.0%
Q2 2013$360,00046,6920.01%
Other shareholders
PDL BIOPHARMA INC shareholders Q4 2013
NameSharesValueWeighting ↓
SMH CAPITAL ADVISORS INC 81,713$176,0000.39%
BRANDES INVESTMENT PARTNERS, LP 5,465,156$11,805,0000.30%
Crestline Management, LP 875,000$1,890,0000.30%
West Family Investments, Inc. 539,450$1,165,0000.29%
WEBER ALAN W 200,000$432,000,0000.19%
Zebra Capital Management LLC 73,910$160,0000.18%
RBF Capital, LLC 569,323$1,230,0000.14%
Leap Investments LP 69,496$150,0000.08%
Connor, Clark & Lunn Investment Management Ltd. 4,387,038$9,476,0000.06%
CHICAGO EQUITY PARTNERS LLC 519,315$1,122,0000.05%
View complete list of PDL BIOPHARMA INC shareholders